Preterm birth is frequently associated with perinatal inflammation, a major risk factor for bronchopulmonary dysplasia, brain damage, and subsequent neurodevelopmental impairments.
1,2 Because glucocorticoids alleviate systemic inflammation, they have been proposed as a therapeutic option in very preterm infants. Quiz Ref ID Postnatal dexamethasone therapy led to short-term benefits, including decreasing the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia, but was associated with cerebral palsy and other adverse neurodevelopmental events.
3